Endevica Bio Revenue and Competitors
Estimated Revenue & Valuation
- Endevica Bio's estimated annual revenue is currently $1M per year.
- Endevica Bio's estimated revenue per employee is $77,500
Employee Data
- Endevica Bio has 13 Employees.
- Endevica Bio grew their employee count by 160% last year.
Endevica Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Executive Chairman | Reveal Email/Phone |
2 | Chief Commercialization Officer | Reveal Email/Phone |
3 | Head Research And Development | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | Research Chemist | Reveal Email/Phone |
Endevica Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $79.1M | 510 | 6% | N/A | N/A |
#2 | $1.1M | 7 | 17% | N/A | N/A |
#3 | $4.2M | 27 | -32% | N/A | N/A |
#4 | $2M | 13 | 30% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $0.9M | 6 | 0% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $3.7M | 24 | 4% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $6M | 39 | 50% | N/A | N/A |
What Is Endevica Bio?
Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
keywords:N/AN/A
Total Funding
13
Number of Employees
$1M
Revenue (est)
160%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 13 | 0% | N/A |
#2 | $0.5M | 13 | -19% | N/A |
#3 | $1.2M | 14 | 0% | N/A |
#4 | $1.3M | 14 | -50% | N/A |
#5 | $35M | 14 | 8% | N/A |